Product
Sleeping Beauty Transposed
1 clinical trial
5 indications
Indication
Endocrine/NeuroendocrineIndication
Breast CancerIndication
Gastrointestinal/Genitourinary CancersIndication
Ovarian CancerIndication
NSCLCClinical trial
A Phase II Study Using the Administration of Autologous T-Cells Engineered Using the Sleeping Beauty Transposon/Transposase System to Express T-Cell Receptors Reactive Against Mutated Neoantigens in Patients With Metastatic CancerStatus: Withdrawn, Estimated PCD: 2024-03-08